Sequencing analysis of the diversity of the B-cell receptor (BCR) repertoire expressed by an individual patient’s total B cell population has scaled up the identification of new potential target antigens for practical evaluation of immune response in cancer (18, 19). This evidence concerns the gene BCR and cancer.